29 kDa outer membrane Antibody

Shipped with Ice Packs
In Stock

Description

Helicobacter pylori (Omp29)

Structure and Function
Omp29 is a highly conserved outer membrane protein in H. pylori, serving as a major antigen during infection. Its gene (omp29) exhibits structural variability due to nucleotide insertions, enabling antigenic diversity to evade host immunity . The protein is recognized by patient sera and has been used as a clinical marker for monitoring infection status .

Therapeutic Potential
Omp29 is a candidate for subunit vaccines due to its surface exposure and immunogenicity. Recombinant Omp29 has shown reactivity with patient sera, indicating its utility in diagnostic assays .

Entamoeba histolytica (29 kDa Surface Antigen)

Structure and Function
This cysteine-rich protein forms disulfide-linked dimers and oligomers on the parasite surface. It is the primary accessible thiol-containing antigen, playing a role in host-parasite interactions .

Immune Response
Monoclonal antibodies differentiate pathogenic from non-pathogenic isolates, highlighting its role in immune recognition. The protein’s oligomeric structure may enhance immune evasion .

Mycobacterium tuberculosis (CFP29)

Structure and Function
CFP29 is a 29 kDa culture filtrate protein released during growth. It exists as a polymer in its native state and shares homology with bacteriocins .

Immune Response
The protein is recognized by T cells in early infection, stimulating IFN-γ production. Its presence in both culture filtrate and membrane fractions suggests dual roles in pathogenesis and immune modulation .

Therapeutic Potential
CFP29 is a candidate for diagnostic markers or vaccine antigens, given its early secretion and T-cell reactivity .

Ehrlichia spp. (P28/P29)

Structure and Function
P28 and P29 are immunodominant outer membrane proteins in Ehrlichia chaffeensis and E. canis. They share epitopes, complicating serological diagnostics .

Immune Response
Convalescent-phase sera from ehrlichiosis patients strongly recognize these proteins, suggesting their role in immune priming .

Therapeutic Potential
Antibodies targeting P28/P29 could inform serodiagnostic assays, though cross-reactivity between species remains a challenge .

Aggregatibacter actinomycetemcomitans (OMP29)

Structure and Function
OMP29 belongs to the OMPA family and mediates invasion of gingival epithelial cells. Its deletion alters host inflammatory responses .

Therapeutic Potential
Targeting OMP29 could reduce bacterial invasion and inflammation, offering a pathway for periodontitis therapies .

Comparison of 29 kDa Outer Membrane Proteins

PathogenProtein NameMolecular Weight (kDa)Key FunctionAntibody ResponseVaccine Potential
H. pyloriOmp2929Antigenic markerPatient sera reactivitySubunit vaccine candidate
E. histolytica29 kDa antigen29Surface adhesionPathogenic isolate-specific Mabs Therapeutic antibody target
M. tuberculosisCFP2929Early T-cell antigenIFN-γ stimulation Diagnostic marker
EhrlichiaP28/P2928/29SerodiagnosisConvalescent-phase recognition Diagnostic assay component
A. actinomycetemcomitansOMP2929Gingival invasionPeriodontitis patient sera Anti-invasion therapy

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
29 kDa outer membrane protein (29 kDa OMP) (Fragment)
Target Names
29 kDa outer membrane protein,partial
Uniprot No.

Target Background

Function
This antibody may be involved in the transport of molecules across the outer membrane.
Subcellular Location
Cell outer membrane.

Q&A

What are 29 kDa outer membrane proteins and why are they significant in microbial pathogen research?

29 kDa outer membrane proteins are surface-associated molecules found in various microbial pathogens that typically function as adhesins or receptors involved in host-cell interactions. In Entamoeba histolytica, the 29 kDa surface-associated molecule appears to be one of the receptors involved in host cell interactions and may modulate amoebic disease processes . Similarly, in Aggregatibacter actinomycetemcomitans (Aa), OMP29 is a member of the OMPA family that mediates the invasion of the pathogen into gingival epithelial cells (GECs) .

These proteins are significant because they often play crucial roles in pathogenesis by facilitating adhesion to host cells, mediating invasion, and sometimes modulating host immune responses. Their surface exposure makes them accessible targets for antibody recognition, which has implications for both diagnostics and potential therapeutic interventions .

How are monoclonal antibodies against 29 kDa outer membrane proteins developed?

Monoclonal antibodies against 29 kDa outer membrane proteins are typically developed through a series of standardized immunological procedures. For example, in the case of the 29 kDa molecule of E. histolytica, researchers generated monoclonal antibodies (specifically MoAb C8) that strongly agglutinated amoebic trophozoites .

For antibodies against Aa OMP29, researchers used a more detailed approach:

  • Expression and purification of recombinant protein (rOMP29)

  • Immunization of Balb/c mice with 50 μg of purified Aa OMP29His with aluminum hydroxide adjuvant (1:1) in a 200 μl volume

  • Administration of booster injections after 7 days, 3, 4, 6, and 7 weeks following the initial challenge

  • Determination of antibody titers using enzyme-linked immunosorbent assay (ELISA)

This systematic approach ensures the production of highly specific antibodies that can recognize the target protein in various experimental contexts.

What techniques are commonly used to detect and characterize 29 kDa outer membrane proteins?

Several techniques are employed to detect and characterize 29 kDa outer membrane proteins:

  • SDS-PAGE (Sodium Dodecyl Sulfate–Polyacrylamide Gel Electrophoresis): Used to resolve outer membrane proteins by molecular weight. For OMP29, researchers note that while the protein has an approximate size of 29 kDa, it appears as a 34 kDa band when denatured in SDS-PAGE .

  • Immunofluorescence: Applied to visualize the localization of the protein. For instance, immunofluorescence of live E. histolytica trophozoites and surface fluorescence of acetone-fixed trophozoites using MoAb C8 confirmed the existence of the 29 kDa molecule on the surface-associated plasma membrane .

  • Western blotting: Employed to verify the specificity of antibodies against the target protein.

  • Outer membrane extraction: Bacterial outer membrane extracts (OMEs) are obtained using established protocols, and the proteins are then resolved by SDS-PAGE .

  • Recombinant protein production: For detailed characterization, recombinant versions of the proteins (such as Aa OMP29His) can be produced and purified for further analysis .

How do antibodies against 29 kDa outer membrane proteins affect pathogen-host interactions?

Antibodies against 29 kDa outer membrane proteins can significantly alter pathogen-host interactions, often by interfering with the pathogen's ability to adhere to or invade host cells. In the case of E. histolytica, prior treatment of trophozoites with MoAb C8 resulted in:

  • Significant (P < 0.01) reduction in adherence of amoebic trophozoites to cultured Chinese Hamster Ovary cells

  • Significant (P < 0.01) reduction in cytotoxicity to cultured Baby Hamster Kidney cells

  • Significant (P < 0.01) reduction in growth of the parasite when pretreated prior to cultivation in TPS-1 medium

These findings suggest that antibodies targeting the 29 kDa surface molecule can effectively disrupt the pathogen's ability to interact with host cells and potentially mitigate disease progression.

What molecular mechanisms underlie the immune evasion strategies involving 29 kDa outer membrane proteins?

29 kDa outer membrane proteins can be involved in sophisticated immune evasion strategies. Research on Aggregatibacter actinomycetemcomitans OMP29 has revealed a novel mechanism:

  • OMP29 and its paralogue OMP29par appear to inhibit the expression of CXCL-8 (IL-8) in gingival epithelial cells

  • This inhibition potentially interferes with the recruitment of neutrophils to the site of infection

  • The proteins also modulate the expression of genes involved in apoptosis and inflammatory response

  • This modulation may dampen the host inflammatory response, creating a more permissive environment for bacterial growth

The evidence for this mechanism comes from experiments showing that:

  • OBA-09 cells challenged with the double mutant strain (AaΔ29Δ29P) exhibited higher expression of cxcl-8 compared to wildtype Aa

  • LPS-stimulated OBA-09 cells treated with recombinant Aa OMP29His showed reduced expressions of cxcl-8 and its protein product CXCL-8

These findings suggest that the 29 kDa proteins actively contribute to immune evasion rather than simply serving as passive adhesins.

How does genetic deletion of outer membrane protein genes affect compensatory expression of other membrane proteins?

Research has revealed interesting compensatory mechanisms when outer membrane protein genes are deleted. In Aggregatibacter actinomycetemcomitans, the deletion of omp29 led to:

  • Overexpression of its paralogue OMP29par

  • Increased expression of another membrane protein, OMP39

  • The expression of OMP39 was further increased in the double mutant (AaΔ29Δ29P)

This compensatory expression pattern suggests:

  • A functional redundancy exists between related outer membrane proteins

  • Bacteria possess sophisticated regulatory mechanisms to maintain membrane integrity and function

  • Single gene knockout studies may be complicated by these compensatory mechanisms, potentially masking phenotypic effects

These findings highlight the importance of creating and studying multiple gene deletion mutants when investigating the functions of outer membrane proteins.

What are the optimal protocols for isolation and purification of 29 kDa outer membrane proteins for antibody production?

The optimal protocols for isolation and purification of 29 kDa outer membrane proteins typically involve:

  • Outer Membrane Extraction: For bacterial pathogens like Aa, outer membrane extracts (OMEs) are obtained using established protocols that separate the outer membrane from other cellular components .

  • Protein Separation: The extracted proteins are resolved by SDS-PAGE (10% acrylamide) to identify and isolate the 29 kDa protein band .

  • Recombinant Protein Production: For more controlled antibody production, researchers often opt for recombinant protein approaches:

    • Cloning the gene encoding the 29 kDa protein into an expression vector

    • Expression in a suitable host system (typically E. coli)

    • Purification using affinity chromatography (often with a His-tag system)

    • Verification of purity using SDS-PAGE with Colloidal blue staining

  • Quality Control: The purified protein should be tested for:

    • Purity (single band on SDS-PAGE)

    • Correct size (approximately 29 kDa, though may appear larger when denatured)

    • Immunoreactivity with existing antibodies if available

    • Functional activity where applicable

This systematic approach ensures high-quality antigen preparation for subsequent antibody production.

What experimental controls are critical when evaluating the effects of anti-29 kDa outer membrane protein antibodies?

When evaluating the effects of anti-29 kDa outer membrane protein antibodies, several critical controls should be included:

  • Isotype Controls: Include antibodies of the same isotype (e.g., IgG1 for MoAb C8) but with irrelevant specificity to control for non-specific effects .

  • Genetic Complementation: When using deletion mutants (e.g., AaΔ29, AaΔ29P, and AaΔ29Δ29P), include genetically complemented strains to confirm that observed phenotypes are due to the specific gene deletion .

  • Recombinant Protein Controls: When using recombinant proteins (e.g., Aa OMP29His), include similarly produced but unrelated proteins to control for contaminants or production-related artifacts .

  • Host Cell Controls: Include untreated host cells (e.g., GECs or CHO cells) and cells treated with non-specific stimuli to establish baseline responses .

  • Concentration Gradients: Test antibodies or recombinant proteins at multiple concentrations to establish dose-response relationships.

  • Multiple Cell Lines: Validate findings across different relevant cell lines to ensure the observed effects are not cell-line specific.

These controls help ensure that the observed effects are specifically attributable to the antibodies against the 29 kDa outer membrane proteins.

How can deletion mutants be effectively used to study the function of 29 kDa outer membrane proteins?

Deletion mutants provide powerful tools for studying the function of 29 kDa outer membrane proteins. The approach used for Aggregatibacter actinomycetemcomitans OMP29 illustrates an effective strategy:

  • Generation of Single and Multiple Deletion Mutants: Create individual deletion mutants (e.g., AaΔ29, AaΔ29P) and combined deletion mutants (e.g., AaΔ29Δ29P) to account for potential functional redundancy .

  • Proteomics Analysis: Analyze changes in protein expression between wildtype and mutant strains to identify compensatory mechanisms, as demonstrated by the overexpression of OMP29par and OMP39 in response to omp29 deletion .

  • Host Cell Response Assays: Compare host cell responses to wildtype and mutant strains. For example:

    • Gene expression analysis (e.g., cxcl-8 expression in GECs)

    • Protein production measurements (e.g., CXCL-8 secretion)

    • Functional assays (e.g., adherence, cytotoxicity)

  • Microarray Analysis: Perform comprehensive gene expression analysis of host cells challenged with wildtype versus mutant strains to identify broader effects on host response pathways .

  • Complementation Studies: Reintroduce the deleted gene(s) to confirm that observed phenotypic changes are specifically due to the absence of the target protein(s).

This systematic approach allows researchers to comprehensively characterize the functions of 29 kDa outer membrane proteins in host-pathogen interactions.

What gene expression analysis approaches best reveal the impact of 29 kDa outer membrane proteins on host cells?

Several gene expression analysis approaches have proven effective in revealing the impact of 29 kDa outer membrane proteins on host cells:

  • Microarray Analysis: This technique provides a comprehensive view of gene expression changes. In the study of Aa OMP29, microarray analysis revealed that deletion of omp29 and omp29par affected the expression of numerous genes involved in apoptosis and inflammatory response in gingival epithelial cells .

  • Targeted qRT-PCR: For focused analysis of specific genes of interest. In the case of Aa OMP29, researchers specifically examined the expression of cxcl-8 in response to different bacterial strains and recombinant proteins .

  • Pathway-Focused Gene Arrays: These allow examination of specific cellular pathways. For Aa OMP29, researchers identified changes in genes involved in:

    • Apoptotic pathways (both pro-apoptotic and anti-apoptotic)

    • Inflammatory response

    • Cell receptor and adhesion molecules

  • Protein Expression Validation: Gene expression findings should be validated at the protein level using techniques like ELISA, as demonstrated for CXCL-8 production in response to Aa OMP29His .

The research demonstrated that cells challenged with the double mutant AaΔ29Δ29P showed increased expression of inflammatory genes (il-1α, il-1β, il-6, cxcl-8, tnfrsf1β) and altered expression of apoptosis-related genes compared to cells challenged with wildtype bacteria, suggesting complex immunomodulatory functions of these outer membrane proteins .

How can researchers reconcile contradictory findings regarding the effects of 29 kDa outer membrane proteins?

Researchers may encounter contradictory findings regarding the effects of 29 kDa outer membrane proteins, as evidenced in the literature. For example, one study found that recombinant Aa OMP29His suppressed cxcl-8 transcription and CXCL-8 production in LPS-stimulated OBA-9 cells, while another study reported that OMP29 induced CXCL-8 in gingival epithelial cells .

To reconcile such contradictions, researchers should:

  • Examine Methodological Differences:

    • Protein purification methods: The study noted that previous research extracted OMP29 directly from Aa outer membrane, which may contain contaminants affecting experimental outcomes .

    • Cell types and conditions: Different epithelial cell lines or primary cells may respond differently.

    • Stimulation conditions: The presence of co-stimuli like LPS can significantly alter responses.

  • Consider Protein Context:

    • Recombinant versus native protein: Structural differences may exist.

    • Presence of binding partners: In their native context, proteins may interact with other membrane components.

  • Evaluate Compensatory Mechanisms:

    • As demonstrated with OMP29 and OMP29par, deletion of one protein may lead to compensatory expression of others, complicating interpretation .

  • Design Definitive Experiments:

    • Use multiple approaches (genetic deletion, recombinant protein, antibody blocking)

    • Include appropriate controls for each method

    • Test in multiple cell types or models

By systematically addressing these factors, researchers can work toward resolving contradictory findings and developing a more accurate understanding of these proteins' functions.

What experimental design considerations are important when studying the multiple roles of 29 kDa outer membrane proteins in pathogenesis?

The 29 kDa outer membrane proteins appear to have multiple roles in pathogenesis, making their study methodologically challenging. Important experimental design considerations include:

  • Comprehensive Genetic Approach:

    • Create both single and multiple deletion mutants (as with AaΔ29, AaΔ29P, and AaΔ29Δ29P)

    • Consider the potential redundancy between paralogous proteins

    • Account for compensatory expression of other proteins

  • Multi-faceted Functional Analysis:

    • Assess multiple potential functions (adhesion, invasion, immune modulation)

    • Use both gain-of-function (recombinant protein addition) and loss-of-function (gene deletion) approaches

    • Examine effects at different concentrations and time points

  • Mechanistic Deconvolution:

    • Design experiments that can distinguish between direct and indirect effects

    • Use pathway inhibitors to identify specific signaling mechanisms

    • Consider sequential events in host-pathogen interactions

  • System-Level Analysis:

    • Combine targeted approaches (e.g., cxcl-8 expression) with broader analyses (microarray)

    • Connect gene expression changes to functional outcomes

    • Consider the net effect of potentially opposing functions (e.g., pro-apoptotic versus anti-apoptotic effects)

The research on Aa OMP29 illustrates this complexity, as the protein appears to influence both inflammatory responses (by suppressing CXCL-8) and apoptotic pathways (affecting both pro-apoptotic and anti-apoptotic genes) in host cells .

What are the most promising therapeutic applications for antibodies targeting 29 kDa outer membrane proteins?

Antibodies targeting 29 kDa outer membrane proteins show several promising therapeutic applications:

  • Inhibition of Pathogen Adhesion and Invasion:

    • The MoAb C8 against E. histolytica 29 kDa molecule significantly reduced adherence to host cells and cytotoxicity

    • Similar approaches could be developed for other pathogens with functionally important outer membrane proteins

  • Modulation of Immune Evasion Strategies:

    • Given that OMP29 and OMP29par from Aa appear to suppress CXCL-8 expression and modulate inflammatory responses, antibodies blocking these functions could potentially restore normal immune responses to infection

  • Combination Therapies:

    • Antibodies against 29 kDa proteins could be combined with conventional antimicrobials to enhance efficacy

    • This approach might be particularly valuable for intracellular pathogens that use these proteins for invasion

  • Diagnostic Applications:

    • The specificity of these antibodies makes them valuable for diagnostic development

    • Point-of-care tests could be developed for rapid identification of specific pathogens

Future research should focus on optimizing antibody formulations, testing in appropriate animal models, and evaluating potential for resistance development through compensatory mechanisms as observed in the deletion studies .

How might systems biology approaches advance our understanding of 29 kDa outer membrane protein functions?

Systems biology approaches offer powerful tools for understanding the complex functions of 29 kDa outer membrane proteins:

  • Integrated Multi-omics Analysis:

    • Combining proteomics, transcriptomics, and metabolomics could reveal how these proteins affect both pathogen and host systems

    • This approach could identify unexpected connections between the 29 kDa proteins and other cellular processes

  • Network Analysis of Host Response:

    • The research on Aa OMP29 already shows complex effects on host gene expression, affecting multiple pathways including inflammation and apoptosis

    • Network analysis could map these changes to identify central nodes and potential intervention points

  • Mathematical Modeling of Host-Pathogen Interactions:

    • Developing quantitative models of how these proteins influence adhesion, invasion, and immune modulation

    • Such models could predict the net outcome of multiple, sometimes opposing effects (e.g., both pro-apoptotic and anti-apoptotic gene expression changes)

  • Comparative Analysis Across Pathogens:

    • Systematic comparison of 29 kDa outer membrane proteins from different pathogens (E. histolytica, Aa, etc.)

    • Identification of conserved structural features and functions despite sequence divergence

These approaches could help resolve some of the contradictions in the literature and provide a more comprehensive understanding of how these proteins contribute to pathogenesis across different disease contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.